Drugmaker to study pig kidney transplants in humans with groundbreaking trial
FDA clears United Therapeutics for human trials of pig-to-human kidney transplants. Trial involves gene-edited pig kidneys ...
New Hampshire man is 2nd person known to be living with a pig kidney
His effort paid off: Tim Andrews, 66, is only the second person known to be living with a pig kidney. Andrews is free from dialysis, Massachusetts General Hospital announced Friday, and recovering so ...
News Medical2d
No extra benefit from mechanical clot removal over medications in some strokes
Removing a clot blocking a medium- or small-sized artery in the brain mechanically is a safe treatment for a common type of stroke; however, it did not lessen disability more than best medical ...
United Therapeutics price target lowered to $460 from $475 at UBS
UBS lowered the firm’s price target on United Therapeutics (UTHR) to $460 from $475 and keeps a Buy rating on the shares. United Therapeutics ...
Le Lézard3d
Love at First Sip: OAKBERRY Teams Up with POM Wonderful to Sweeten Up National Heart Month and Valentine's Day with a Limited-Time Smoothie
OAKBERRY, the global quick-service superfood brand with always fresh açaí, has teamed up with POM Wonderful to launch the all ...
New Data Presented at the International Stroke Conference Further Validates Treatment Impact of Brainomix 360
Brainomix, an award-winning pioneer of state-of-the-art artificial intelligence (AI) imaging solutions, will be unveiling a ...
United Therapeutics: TETON 1 study of nebulized Tyvaso for IPF fully enrolled
United Therapeutics (UTHR) announced full enrollment of the TETON 1 study evaluating the use of Tyvaso or treprostinil, inhalation solution or ...
Thryv Therapeutics to Participate in the 2025 Leerink Partners Global Healthcare Conference in Miami, FL
Thryv Therapeutics Inc., a clinical-stage biotechnology company pioneering novel therapies for cardiovascular diseases, is ...